ADHD is still frequently discussed as though its most important consequences occur during childhood, education and the early working years. Yet people with ADHD grow older, and many adults reach their fifties, sixties or seventies having spent much of their lives without a diagnosis. We know considerably less about what happens to their cognitive functioning as they age than we do about ADHD in children and young adults.
A new study published in JAMA Psychiatry on 7 October 2026 raises an important question about this neglected period of life. Researchers examined whether ADHD diagnoses and genetic susceptibility to ADHD were associated with subsequent mild cognitive impairment or dementia.
The findings deserve attention, but they also require careful interpretation. There is a substantial difference between demonstrating an association with cognitive impairment and establishing that ADHD causes neurodegeneration.
The study used data from 187,341 adults aged 50 years and older participating in the US All of Us Research Program. Of these, 3,026 had a recorded ADHD diagnosis. Participants were followed for an average of approximately ten years, using electronic health records and genomic data.
During follow-up, mild cognitive impairment or dementia was recorded in 6.7% of participants with ADHD, compared with 3.4% of those without an ADHD diagnosis.
In an adjusted statistical model, ADHD was associated with a substantially higher hazard of subsequent cognitive impairment. The association became smaller when additional health and psychiatric conditions were taken into account, but it did not disappear.
The researchers also examined polygenic risk scores, which estimate genetic susceptibility based on many genetic variants. Participants in the highest ADHD polygenic risk group had a modestly higher hazard of cognitive impairment than those in the lowest group.
This genetic component makes the findings particularly interesting. It provides a second perspective on the relationship beyond recorded clinical diagnoses, although it does not establish a direct causal pathway.
One of the difficulties in studying ADHD in older adults is that some of its characteristic features overlap with the complaints that lead people to seek assessment for cognitive decline.
Forgetfulness, distractibility, difficulty organising information and losing track of tasks can all occur in ADHD. They can also appear in depression, sleep disorders, medication-related difficulties and neurodegenerative conditions.
The clinical distinction is therefore not simply whether someone forgets things or struggles to concentrate. It is also about their developmental history, the pattern of symptoms over time and whether there has been a meaningful change from their previous level of functioning.
Someone who has experienced lifelong difficulties with working memory may become more concerned about those difficulties as they age, particularly when everyday demands increase or previously effective compensatory strategies become harder to maintain.
Conversely, a new and progressive deterioration in memory or daily functioning should not automatically be attributed to an existing ADHD diagnosis.
Both mistakes are possible: overlooking lifelong ADHD in an older person, and overlooking an emerging cognitive disorder because the person already has ADHD.
The researchers were careful to acknowledge several limitations.
This was an observational study based substantially on health records. Such records can identify important patterns across large populations, but they do not necessarily capture when ADHD symptoms first began, how accurately the diagnosis was established or how cognitive difficulties developed before a formal diagnosis appeared.
Reverse causation is a particular concern. Cognitive changes that precede a dementia diagnosis can emerge years before the condition is recognised. Some of those early difficulties may be interpreted as attentional problems, complicating the relationship between the timing of ADHD diagnoses and subsequent cognitive impairment.
The researchers found that the association weakened in analyses requiring longer intervals between the ADHD diagnosis and cognitive impairment, although it did not disappear entirely.
Other factors may also contribute, including psychiatric comorbidities, physical health conditions, differences in healthcare access and patterns of clinical assessment.
Importantly, the study could not establish whether ADHD treatment changes the likelihood of later cognitive impairment.
It would therefore be premature to interpret these findings as evidence that ADHD itself causes dementia, or that a particular treatment prevents it.
For decades, ADHD research concentrated heavily on childhood. Adult ADHD has attracted considerably more attention in recent years, but older adults remain relatively underrepresented.
This matters because the challenges associated with ADHD do not necessarily remain constant across the lifespan.
Employment, family responsibilities, physical health, sleep, social support and the demands placed on executive functioning all change with age. Some people develop effective strategies that allow them to function well for decades. Others may find that those strategies become less reliable as circumstances change.
We also need to distinguish between cognitive capacity and the effort required to maintain everyday functioning. Two people may achieve similar outcomes while relying on very different levels of compensation, external structure and deliberate control.
When an older adult reports that everyday tasks have become harder, understanding their previous functioning may be just as important as measuring their current performance.
From a research perspective, longitudinal studies that combine developmental history, repeated cognitive assessments, clinical diagnoses and measures of real-world functioning would be particularly valuable.
They could help clarify whether ADHD is associated with changes in cognitive ageing itself, whether shared risk factors explain part of the relationship, and how lifelong executive-function difficulties interact with emerging age-related changes.
The most useful conclusion is not that adults with ADHD should be frightened about their future cognitive health.
It is that ADHD deserves a place in serious conversations about cognitive ageing.
Clinicians assessing older adults need to consider lifelong attentional and executive-function patterns, while remaining alert to genuine changes in cognitive functioning. Researchers need better ways to distinguish longstanding difficulties from emerging impairment and to understand the role of associated health conditions.
For adults living with ADHD, the findings reinforce the importance of taking cognitive concerns seriously without assuming that every lapse in attention or memory signals something more serious.
ADHD does not disappear when someone turns 50. Our research questions should not stop there either.
Reference
Bauer-Negrini, G., Leffa, D. T., Ferreira, P. C. L., et al. (2026). Attention-deficit/hyperactivity disorder and late-life cognitive impairment. JAMA Psychiatry. Published online October 7, 2026. https://doi.org/10.1001/jamapsychiatry.2026.3165
Related reading
For more information about how ADHD can change across different stages of life, explore my ADHD across the lifespan FAQs, including questions about adult diagnosis, hormonal transitions and cognitive ageing.